NanoAssemblr™ Spark nanoparticle formulation system
Fast and intuitive system for nanoparticle formulation development in microliter volumes for discovery and screening.
Receive your quote directly from the manufacturer.
You want to formulate for drug development
Lipid nanoparticles
Incredible repeatability. Sensational for formulations
Review Date: 30 Mar 2022 | Cytiva
The NanoAssemblr™ Spark nanoparticle formulation system enables the production of nanoparticle formulation in volumes ranging from 25 – 250 μL, ideal for discovery and screening that involves scarce or expensive nucleic acids and nanoparticle excipients.
- Robust process and feedback - Electronic control minimizes batch-to-batch and user variability while providing real-time feedback to help optimize your formulation
- Rapid production - Simply pipette starting materials into wells, and with the press of a button, the formulation is ready in seconds, allowing hundreds of formulations to be made in just a few hours
- Workflow integration - Designed for operation in a sterile biosafety hood, the formulations can be made on-demand and applied to cells in culture
- Scalable – Leveraging NxGen™ mixing technology, the formulations can be seamlessly scaled across the NanoAssemblr™ platform, accelerating future development
- Exceptional sample recovery - Advanced NxGen™ mixing technology allows the formulation of microliter volumes with near complete sample recovery
The Nanoassemblr™ Spark system enables robust low-volume RNA-lipid nanoparticle (LNP) formulations ideal for drug discovery and early preclinical development.
Simple, easy workflow
Formulations on the Nanoassemblr™ Spark™ system are ready in seconds. Plus, they can be made on-demand in a sterile hood for immediate cell culture applications.
Applications
- Nucleic acid delivery and screening
- Nanoparticle design and screening
- Drug discovery and target validation
